ClariVest Asset Management LLC lessened its holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) by 17.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 266,122 shares of the medical instruments supplier’s stock after selling 57,934 shares during the period. ClariVest Asset Management LLC owned about 0.45% of OraSure Technologies worth $5,988,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. BlackRock Inc. increased its stake in OraSure Technologies by 127,593.4% during the 1st quarter. BlackRock Inc. now owns 7,743,325 shares of the medical instruments supplier’s stock worth $100,123,000 after buying an additional 7,737,261 shares in the last quarter. Vanguard Group Inc. increased its stake in OraSure Technologies by 19.8% during the 2nd quarter. Vanguard Group Inc. now owns 5,352,832 shares of the medical instruments supplier’s stock worth $92,390,000 after buying an additional 886,333 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in OraSure Technologies by 5.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,057,690 shares of the medical instruments supplier’s stock worth $52,777,000 after buying an additional 167,642 shares in the last quarter. Daruma Capital Management LLC increased its stake in OraSure Technologies by 2,761.0% during the 2nd quarter. Daruma Capital Management LLC now owns 2,821,506 shares of the medical instruments supplier’s stock worth $48,699,000 after buying an additional 2,722,886 shares in the last quarter. Finally, Acadian Asset Management LLC increased its stake in OraSure Technologies by 32.5% during the 2nd quarter. Acadian Asset Management LLC now owns 1,846,854 shares of the medical instruments supplier’s stock worth $31,877,000 after buying an additional 452,642 shares in the last quarter. Hedge funds and other institutional investors own 92.93% of the company’s stock.

A number of research firms have recently issued reports on OSUR. ValuEngine lowered OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Canaccord Genuity upped their price target on OraSure Technologies from $21.00 to $22.00 and gave the company a “buy” rating in a research report on Thursday, August 3rd. Zacks Investment Research upgraded OraSure Technologies from a “hold” rating to a “buy” rating and set a $25.00 price target for the company in a research report on Wednesday, September 20th. Jefferies Group LLC lowered OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Finally, BidaskClub lowered OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $18.21.

ILLEGAL ACTIVITY WARNING: “OraSure Technologies, Inc. (OSUR) Position Decreased by ClariVest Asset Management LLC” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/19/orasure-technologies-inc-osur-position-decreased-by-clarivest-asset-management-llc.html.

OraSure Technologies, Inc. (NASDAQ:OSUR) traded down $0.35 during mid-day trading on Friday, hitting $13.74. The stock had a trading volume of 1,172,898 shares, compared to its average volume of 1,344,396. The stock has a market capitalization of $833.30, a price-to-earnings ratio of 26.42, a PEG ratio of 2.64 and a beta of 1.39. OraSure Technologies, Inc. has a 1-year low of $8.21 and a 1-year high of $23.01.

OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.09. OraSure Technologies had a return on equity of 14.12% and a net margin of 20.48%. The business had revenue of $42.30 million during the quarter, compared to analyst estimates of $40.87 million. During the same period in the prior year, the business earned $0.11 earnings per share. The business’s revenue was up 31.0% compared to the same quarter last year. equities research analysts anticipate that OraSure Technologies, Inc. will post 0.42 earnings per share for the current year.

In related news, CEO Douglas A. Michels sold 22,923 shares of the company’s stock in a transaction that occurred on Wednesday, October 4th. The stock was sold at an average price of $23.00, for a total value of $527,229.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Brian Smith sold 9,112 shares of the company’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $20.47, for a total value of $186,522.64. Following the completion of the transaction, the insider now owns 32,477 shares in the company, valued at $664,804.19. The disclosure for this sale can be found here. Insiders sold 61,110 shares of company stock worth $1,362,463 over the last quarter. 6.40% of the stock is currently owned by insiders.

About OraSure Technologies

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR).

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Stock Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related stocks with our FREE daily email newsletter.